坦尼克酸在乙氨基 (APAP) 诱导的急性肝衰竭中的潜在应用
Yong-Heng Lin1, Yu-Che Lin1, Yung-Te Hou1
1Department of Biomechatronics Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 10617, Taiwan.
International journal of molecular sciences
|January 11, 2024
概括
酸 (TA),一种天然的多,在治疗肝功能衰竭方面显示出显著的潜力. 它增强了肝细胞的活力和功能,提供了对乙氨基诱导的肝损伤的保护和治疗效果.
科学领域:
- 生物化学 生物化学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝衰竭是一种严重的疾病,治疗选择有限.
- 乙氨基 (APAP) 过量服用是导致急性肝损伤的常见原因.
- 像酸 (TA) 这样的天然化合物正在探索其治疗益处.
研究的目的:
- 研究酸 (TA) 的肝脏保护和肝脏治疗作用.
- 在肝衰竭的体外和体内模型中评估TA的疗效,包括APAP诱导的毒性.
主要方法:
- 在体外研究中使用受伤的成熟肝细胞 (MHs) 和具有或没有TA的小肝细胞 (SHs).
- 在体内研究涉及急性肝衰竭和APAP诱导的毒性小鼠.
- 评估肝细胞活力,白蛋白合成,血清酶水平 (ALT,AST),总胆红素,以及组织学分析.
主要成果:
- 在预防和治疗的体外模型中,TA显著增加了肝细胞活力和白蛋白合成.
- 在体内,TA的使用减轻了肝损伤,并减少了APAP后肝损伤毒性的血清标志物.
- 用TA治疗的肝细胞表现出受伤后的恢复和对后续损伤的保护.
结论:
- 酸在特定度下增强肝功能和活力.
- TA对APAP诱导的肝损伤具有保护性和治疗性.
- TA在治疗乙氨基引起的肝功能衰竭方面具有显著的临床潜力.
相关概念视频
Phase II Reactions: Acetylation Reactions
229
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
229
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
212
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
212
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
238
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
238
Prevention of Further Absorption of Poison
824
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
824
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
202
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
202


